• 2016 September 30

Company Description

Arbele Corp is a biotech R&D company focusing on next-gen immunotherapeutic platforms to treat cancer of high mortality

Arbele focuses on acceleration and expansion of immunotherapy technology and product development to treat cancers prevalent in Greater China, Asia-Pacific region and the United States. The company has established a stellar collaboration network with leading academic institutes, biotechs, and medical centers to progress the clinical stages of drug candidates. The company is founded by reputable scientists and senior executives in drug industries and recently teamed up with experienced professionals in financing, legal and investment.